RxDoctor Payments Data

Michael Soulen, MD

Vascular & Interventional Radiology · Philadelphia, PANPI 1447296579

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $122,916 of the $155,073 with a category attached, or 79.3%. Guerbet LLC accounts for 77.2% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $105,224, 10.0 times the $10,561 reported in 2019. Among vascular & interventional radiology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$155,073in general payments, 2019–2025

Across 63 payments — averaging $2461.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Guerbet LLC$120K
  • Instylla, Inc.$9K
  • Sirtex Medical Inc$7K
  • AstraZeneca$6K
  • Siemens Medical Solutions USA, Inc.$5K
  • Advanced Accelerator Applications$3K
  • plus $6K from 7 others
$3,476,963in research payments, 2019–2025

Across 44 payments — averaging $79,022 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Guerbet LLC$1.8M
  • Pfizer$885K
  • Sirtex Medical Inc$721K
  • Lantheus Medical Imaging, Inc.$42K
  • Boston Scientific$6K

What the payments were for

  • Consulting fees$122,91679%
  • Speaking & faculty fees$3,8302%
  • Travel & lodging$24,36616%
  • Food & beverage$3,9613%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$155,073 in reported general payments places this provider in the 95th percentile of 223 vascular & interventional radiology providers in Pennsylvania.

See all vascular & interventional radiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$67,095
Medicare patients
151
Services billed
528

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →